| Tittel: | Improving access to COVID-19 treatments: how IP makes it possible | | Ansvar: | Jhon Carmona Carmona | | Forfatter: | Carmona, Jhon Carmona  | | Materialtype: | Artikkel - elektronisk | | Signatur: | WIPO Magazine | | Utgitt: | Geneva : WIPO, 2021 | | Omfang: | S. 10-12 | | ISBN/ISSN: | 1564-7854 | | Serie: | WIPO Magazine ; 4/2021 | | Emneord: | Immaterialrett / Korona - COVID-19 / Vaksine | | Note: | Open access Attribution 4.0 International (CC BY 4.0) | | Innhold: | Some great news broke recently for the worldwide treatment of COVID-19: the Medicines Patent Pool, a UN-backed non-profit organization, of which WIPO is a board member, agreed to work with Pfizer and Merck Sharp & Dohme (MSD), for the licensing of anti-viral pills − MSD’s molnupiravir and Pfizer’s PF-07321332 − in nearly 100 low- and middle-income countries. | | Del av verk: | WIPO Magazine 4/2021 |
|
|